Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)

Cytokine

Volumn 22, Issue 5, 2003, Pages 142-148

  Mariño, Eliana ^a   Cardier, José E ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Apoptosis; Endothelial cells; Fas; Interleukin 18; Liver endothelial cells; Tumor necrosis factor

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; FAS ANTIGEN; INTERLEUKIN 18; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL LINE; CLINICAL MEDICINE; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; GENETICS; HAMSTER; LIVER CELL; LIVER DISEASE; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; UPREGULATION;

EID: 0038046610     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00150-9     Document Type: Article

References (34)

1. Tsutsui H., Matsui K., Okamura H., Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev. 174:2000;192-209.
2. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem. 272:1997;25737-25742.
3. Dinarello C.A. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 103:1999;11-24.
4. Kohno K., Kurimoto M. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol. 86:1998;11-15.
5. Jonsson J.R., Edwards-Smith C.J., Catania S.C., Morotomi Y., Hogan P.G., Clouston A.D., et al. Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes. J Hepatol. 32:2000;392-398.
6. Park C.-C., Morel J., Amin M., Connors M., Harlow L., Koch A. Evidence of IL-18 as a novel angiogenic mediator. J. Immunol. 167:2001;1644-1653.
7. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L., Fuentes A.M., Anasagasti M.J., Martin J., et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci USA. 97:2000;734-739.
8. Gerdes N., Sukhova G.-K., Libby P., Reynolds R.-S., Young J.-L., Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 195:2002;245-257.
9. Tsutsui H., Matsui K., Kawada N., Hyodo Y., Hayashi N., Okamura H., et al. IL-18 accounts for both TNF-alpha-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol. 159:1997;3961-3967.
10. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 89:2001;E41-E45.
11. McGuinness P.-H., Painter D., Davies S., McCaughan G.-W. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut. 46:2000;260-269.
12. Pomerantz B.-J., Reznikov L.-L., Harken A.-H., Dinarello C.-A. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci USA. 98:2001;2871-2876.
13. Bannerman D.-D., Tupper J.-C., Erwert R.-D., Winn R.-K., Harlan J.-M. Divergence of bacterial lipopolysaccharide pro-apoptotic signaling downstream of IRAK-1. J Biol Chem. 277:2002;8048-8053.
14. Janin A., Deschaumes C., Daneshpouy M., Estaquier J., Micic-Polianski J., Rajagopalan-Levasseur P., et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood. 99:2002;2940-2947.
15. Orange J., Salazar-Mather T., Opal S., Biron C. Mechanisms for virus induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol. 71:1997;9248-9258.
16. Galle P., Hofmann W., Walczak H., Schaller H., Otto G., Stremmel W., et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 182:1995;1223-1230.
17. Leist M., Gantner G., Jilg S., Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J Immunol. 154:1995;1307-1316.
18. Nagaki M., Muto Y., Ohnishi H., Yasuda S., Sano K., Naito T., et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology. 106:1994;450-458.
19. Cardier J.-E., Schulte T., Kammer H., Kwak J., Cardier M. Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells. FASEB J. 13:1999;1950-1960.
20. Cardier J., Barberá-Guillem E. Extramedullary hematopoiesis in the adult mouse liver is associated with specific hepatic sinusoidal endothelial cells. Hepatology. 26:1997;165-175.
21. Cardier J.-E., Dempsey J. Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood. 91:1998;923-929.
22. Horan P.-K., Kappler J.-H. Automated fluorescent analysis for cytotoxicity assays. J Immunol Methods. 18:1977;309-316.
23. Koopman G., Reutelingsperger G., Kuitjen R., Keehnen R., Pals S., van Oers M. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
24. Cohen J. Apoptosis. Immunol Today. 14:1993;126-130.
25. Cardier J.-E., Erickson-Miller C.-L. Fas (CD95)- and tumor necrosis factor-mediated apoptosis in liver endothelial cells: role of caspase-3 and the p38 MAPK. Microvasc Res. 63:2002;10-18.
26. Bannerman D.-D., Tupper J.-C., Ricketts W.-A., Bennett C.-F., Winn R.-K., Harlan J.-M. A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem. 276:2001;14924-14932.
27. Wong G., Goeddel D. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol. 152:1994;1751-1755.
28. Clément M., Stamenkovic I. Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med. 180:1994;557-567.
29. Chen G., Goeddel D. TNF-R1 Signaling: a beautiful pathway. Science. 296:2002;1634-1636.
30. Friedlander R.-M., Gagliardini V., Rotello R.-J., Yuan J. Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis. J Exp Med. 184:1996;717-724.
31. Henkart P.-A. ICE family proteases: mediators of all apoptotic cell death? Immunity. 4:1996;195-201.
32. Rathmell J.-C., Thompson C.B. The central effectors of cell death in the immune system. Annu Rev Immunol. 17:1999;781-828.
33. Monney L., Otter I., Olivier R., Ozer H.L., Haas A.L., Omura S., et al. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J Biol Chem. 273:(11):1998;6121-6131.
34. McCarthy N.J., Whyte M.K., Gilbert C.S., Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol. 136:(1):1997;215-227.